BEIJING, Jan. 14, 2026 /PRNewswire/ — Autozi Internet Technology (Global) Ltd. ("Autozi" or the "Company") (Nasdaq: AZI), one of China’s leading and fastest-growing lifecycle automotive service and supply-chain technology platforms, announced today that it received a notification letter from The Nasdaq Stock Market LLC ("Nasdaq") dated January 13, 2026. In the notification letter, Nasdaq notified the Company that it has regained compliance with the minimum market value of listed securities requirement under Nasdaq Listing Rule 5450(b)(2)(A). Nasdaq further notified the Company that it is in compliance with all applicable continued listing standards. As a result, the previously scheduled hearing before the Hearings Panel on January 22, 2026 has been cancelled, and the Company’s Class A ordinary shares will continue to be listed and traded on the Nasdaq Global Market.

About Autozi

Founded in 2010, Autozi is a fast-growing automotive service and technology platform in China. The company offers a broad portfolio of high-quality, cost-effective automotive products and services through online and offline channels nationwide. Using its advanced supply chain cloud platform and SaaS solutions, Autozi has built an integrated ecosystem that connects key stakeholders across the automotive industry, enhancing collaboration and efficiency throughout the supply chain.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

HTX Research Report Spotlights SunPerp as the Breakout Player in the 2025 Perpetual DEX Boom

PANAMA CITY, Oct. 27, 2025 /PRNewswire/ — HTX Research, the dedicated research…

US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable Therapy

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s new…

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of…